Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
Substance Name: ONO 4641
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
The Sphingosine 1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Post-Infarction Left Ventricular Remodeling in a Porcine Model of Ischemia-Reperfusion.
Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
Remyelination: The True Regeneration of the Central Nervous System.
OASIS is Automated Statistical Inference for Segmentation, with applications to multiple sclerosis lesion segmentation in MRI.
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
Prognostic factors of acute partial transverse myelitis.
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
[Magnetic reasonance spectroscopy-guided stereotactic biopsy for brain lesion].
Neuromodulation of lower limb motor control in restorative neurology.
[Biomarkers in neuromyelitis optica].
Kv1.3 Deletion Biases T Cells toward an Immunoregulatory Phenotype and Renders Mice Resistant to Autoimmune Encephalomyelitis.
Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses.
Teaching NeuroImages: MRI time lag with acute disseminated encephalomyelitis.
Multiple sclerosis and oral health--an update.
Multiple Sclerosis Disease Progression and Paradichlorobenzene: A Tale of Mothballs and Toilet Cleaner.
Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE.
Oral BG-12 in multiple sclerosis.
Imaging new lesions: Enhancing our understanding of multiple sclerosis pathogenesis.
Therapeutic Armamentarium and Health System Coverage of Multiple Sclerosis in Latin America.
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.
Pages
« first
‹ previous
…
192
193
194
195
196
197
198
199
200
…
next ›
last »